Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Biohaven Ltd (NYSE: BHVN) closed the day trading at $13.95 down -6.06% from the previous closing price of $14.85. In other words, the price has decreased by -$6.06 from its previous closing price. On the day, 2.73 million shares were traded. BHVN stock price reached its highest trading level at $14.815 during the session, while it also had its lowest trading level at $13.65.
Ratios:
For a better understanding of BHVN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.82 and its Current Ratio is at 3.82. In the meantime, Its Debt-to-Equity ratio is 2.17 whereas as Long-Term Debt/Eq ratio is at 2.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Citigroup on September 17, 2025, initiated with a Buy rating and assigned the stock a target price of $28.
On September 03, 2025, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $75.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on May 19, 2025, while the target price for the stock was maintained at $21.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’25 when CHILDS JOHN W bought 32,700 shares for $30.47 per share. The transaction valued at 996,238 led to the insider holds 2,320,571 shares of the business.
CHILDS JOHN W bought 29,000 shares of BHVN for $1,042,393 on Dec 30 ’24. The Director now owns 2,368,741 shares after completing the transaction at $35.94 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 1475784448 and an Enterprise Value of 1105258368.
Stock Price History:
The Beta on a monthly basis for BHVN is 3.50, which has changed by -0.7236695 over the last 52 weeks, in comparison to a change of 0.15566266 over the same period for the S&P500. Over the past 52 weeks, BHVN has reached a high of $54.98, while it has fallen to a 52-week low of $12.79. The 50-Day Moving Average of the stock is -10.37%, while the 200-Day Moving Average is calculated to be -32.73%.
Shares Statistics:
Over the past 3-months, BHVN traded about 2.26M shares per day on average, while over the past 10 days, BHVN traded about 2181280 shares per day. A total of 105.78M shares are outstanding, with a floating share count of 92.38M. Insiders hold about 12.68% of the company’s shares, while institutions hold 76.95% stake in the company. Shares short for BHVN as of 1760486400 were 10304537 with a Short Ratio of 4.57, compared to 1757894400 on 13187804. Therefore, it implies a Short% of Shares Outstanding of 10304537 and a Short% of Float of 10.95.
Earnings Estimates
Investors are keenly observing as 6.0 analysts analyze and rate. The current performance of Biohaven Ltd (BHVN) in the stock market.The consensus estimate for the next quarter is -$1.47, with high estimates of -$1.15 and low estimates of -$1.81.
Analysts are recommending an EPS of between -$5.94 and -$6.87 for the fiscal current year, implying an average EPS of -$6.37. EPS for the following year is -$5.39, with 6.0 analysts recommending between -$4.69 and -$6.29.
Revenue Estimates
Based on 17 analysts’ estimates, the company’s revenue will be $95.99M in the next fiscal year. The high estimate is $215.28M and the low estimate is $14.44M.
